☆ 4.6 Letter

Authors' Reply to Huang and Zhang: Comment on Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study

DRUGS (2023)

Related references

Note: Only part of the references are listed.
Letter Pharmacology & Pharmacy

Comment on: Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study

Jin-Xian Huang et al.

DRUGS (2023)

Add to Collection
Article Pharmacology & Pharmacy

Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study

Qiang Tong et al.

Summary: This study evaluated and compared the risk of erectile dysfunction (ED) associated with the use of allopurinol and febuxostat in adult male gout patients. It found that febuxostat was associated with a higher risk of ED than allopurinol in gout patients aged 19-64, but there was no significant difference in ED risk between the two drugs in gout patients older than 65.

DRUGS (2022)

Add to Collection
Article Peripheral Vascular Disease

Urate-lowering therapy exerts protective effects against hypertension development in patients with gout

Kuan-Hung Lin et al.

Summary: This study found that gout patients undergoing urate-lowering therapy (ULT) had lower risks of incident hypertension and diabetes mellitus, and the protective effect of xanthine oxidase inhibitors seemed to have a dose-response relationship.

JOURNAL OF HUMAN HYPERTENSION (2021)

Add to Collection
Review Rheumatology

Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan

Kuang-Hui Yu et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)

Add to Collection
Article Rheumatology

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol

Fernando Perez-Ruiz et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.